ERBB2 and breast neoplasm: As well, agonistic antibody triggering of 4-1BB increased the response of mouse NK cells in mice bearing human Her2-overexpressing breast tumor cells and given Trastuzumab (anti-Her2 mAb) treatment (Kohrt et al., 2012).